(G-I) Sections (magnification, 20ϫ) of hippocampus from 12-month-old mice coexpressing Hu PS1-A246E and APP swe stained with 10D5 (G), 6E10 (H), and 4G8 (I). The 4G8 antibody appears to preferentially recognize the more compact deposits.
ratio of A␤1-42/43 to A␤1-40 is elevated by ‫%05ف‬ in found in AD brain and in aged nonhuman primates (Martin et al., 1994) . doubly transgenic mice expressing APP swe and Hu PS1-A246E as compared with transgenic mice expressing APP swe alone or doubly transgenic mice coexWild-Type Hu PS1 Does Not Accelerate A␤ Deposition pressing wild-type Hu PS1 and APP swe (Borchelt et al., 1996b) .
To determine whether the acceleration in A␤ deposition was due solely to the coexpression of Hu PS1 with APP Brain tissues from animals that coexpress Hu PS1-A246E (line N-5) and APP swe (line C3-3) were stained swe, we examined the brains of age-matched 12-monthold animals coexpressing APP swe (line C3-3) and wildwith A␤ monoclonal antibodies (mAb) 10D5 (Games et al., 1995) , 4G8, and 6E10 (Kim et al., 1990) ; the latter type Hu PS1 (line S8-4; Figure 3 ). We document that, in contrast to mice coexpressing APP swe and Hu PS1-antibody is specific for Hu A␤ (Kim et al., 1990; Borchelt et al., 1996a) . The hippocampus A246E, 12-month-old mice coexpressing APP swe and wild-type Hu PS1 were free of A␤ deposits (Figures 3B and frontal cortex ( Figure 1D ) of these animals invariably contained numerous amyloid deposits that were immuand 3D). Notably, previous characterizations of wildtype Hu PS1 mRNA expression in line S8-4 demonnoreactive with all three antibodies (Figure 1G, 10D5; Figure 1H, 6E10; Figure 1I, 4G8) . The brains from agestrated that the levels of transgene-derived mRNA are approximately fivefold higher in the S8-4 line than the matched littermates expressing APP695 swe alone (Figures 1B and 1E) or from littermates expressing Hu N-5 line, which expresses Hu PS1-A246E (Thinakaran et al., 1996; Lee et al., 1997) . Thus, even when expressed PS1-A246E alone ( Figures 1C and 1F) were free of A␤ deposits. A␤ deposits ( Figure 2A) were also detected at considerably higher levels than FAD-linked mutant PS1, wild-type Hu PS1 neither elevates A␤1-42 producby conventional silver impregnation methods (Nakano and Hirano, 1987;  Figure 2B ). Many of the large argention (Borchelt et al., 1996b) nor promotes A␤ deposition. tophilic amyloid deposits contained dystrophic neurite profiles ( Figure 2B , arrowheads) that also showed APP FAD-Linked Hu PS1-A246E Dramatically Accelerates the Rate of A␤ Deposition immunoreactivity with the APP-specific antibody CT15 (Sisodia et al., 1993; , a reagent To determine the degree to which coexpression of Hu PS1-A246E with APP swe accelerated the rate of amythat has previously been used to visualize dystrophic neurites in aged nonhuman primates (Martin et al., loid deposition, we compared the extent and frequency of A␤ deposits in 9-, 10-, and 11-month-old animals 1994). Many deposits ( Figure 2D ) were also associated with reactive astrocytes as revealed by immunostaining coexpressing APP swe and Hu PS1-A246E to that of animals (of varied ages) expressing APP swe alone (Figwith antibodies to glial fibrillary acidic protein (GFAP; Figure 2E ). Notably, nuclei with the features normally ure 4; Table 1 ). The number of A␤ deposits in 9-monthold animals coexpressing APP swe and Hu PS1-A246E associated with microglia were present in some of the larger deposits (see Figure 2C) Twelve-month-old mice doubly transgenic for Hu PS1-A246E and APP swe were examined by silver impregnation methods (Nakano and Hirano, 1987) and immunostaining for A␤ (10D5), APP C-terminal epitopes (CT15), and GFAP.
(A) A compact A␤ deposit in the hippocampus immunostained with the 10D5 antibody.
(B) A large A␤ deposit in the hippocampus with neurites stained by silver impregnation methods (Nakano and Hirano, 1987) ; the dystrophic neurites are marked by arrowheads. (C) A large plaque in the hippocampus stained with APP-specific CT-15 antisera (Sisodia et al., 1993; far exceeding the number of deposits in much older the brain (Borchelt et al., 1996a) . Moreover, examinations of brain tissues from 9-and 12-month-old mice mice expressing APP swe alone. Collectively, these data convincingly demonstrate that the Hu PS1-A246E acts expressing Hu PS1-A246E alone (n ϭ 4) showed normal synergistically with APP swe to accelerate amyloid deposition.
In our analyses of younger 9-and 10-month-old animals coexpressing APP swe and Hu PS1-A246E, it appeared that the initial deposits were most frequently observed in the hippocampus near the ventricles, in the subiculum, and in the occipital and frontal cortices. Even up to the age of 12 months, A␤ deposits have not been detected in any region of the brain other than the cortex and hippocampus (data not shown), despite relatively high levels of expression of the transgene throughout Accelerates the Rate of A␤ Deposition pressing APP swe and wild-type Hu PS1 were immunostained with mAb 6E10 for A␤ deposits.
The brains of 9-, 10-, and 11-month-old animals coexpressing APP swe and Hu PS1-A246E were compared to that of 18-month-old (A and C) Hippocampus and frontal cortex, respectively, of a 12-month-old animal coexpressing APP swe and Hu PS1-A246E.
animals expressing APP swe alone (these 18-month-old APP swe mice were the dams of the double APP swe ϫ PS1 transgenic (B and D) Hippocampus and frontal cortex of a 12-month-old animal coexpressing APP swe and wild-type Hu PS1.
animals). All sections were immunostained with mAb 6E10. Because assigning numerical values to A␤-deposit loads is somewhat subjective, we chose to use an arbitrary unit system to classify the relative A␤ deposit loads of various animals. Animals with low numbers of A␤ deposits per sagittal section through the cortex and hippocampus, as exemplified by the 9-month-old APP swe ϫ Hu PS1-A246E ( Figure 4A ) were assigned a single (ϩ). Animals with 5-20 A␤ deposits per section (not counting small satellite deposits that surround the large neuritic deposits) were assigned (ϩϩ), and animals with Ͼ20 A␤ deposits per section (not counting satellites) were assigned (ϩϩϩ , 1997) . Using these latter reagents, the patobvious impact on the mouse nervous system, apart from its influence on amyloid deposition in cortical and terns of immunoreactivity in human AD brain and the double transgenic mice were indistinguishable from the hippocampal regions.
patterns observed with Ab40 and Ab42. A␤ Deposits in Mice Coexpressing Hu PS1-A246E and APP swe Contain Both A␤1-40 Discussion and 1-42 Epitopes To characterize the A␤ deposits in mice coexpressing This report demonstrates that the coexpression of APP swe with Hu PS1-A246E, but not wild-type Hu PS1, Hu PS1-A246E and APP swe, tissue sections were stained with antisera Ab40 and Ab42, which are specific greatly accelerates the rate of A␤ deposition in the brains of transgenic mice. These new data extend our for A␤ peptides terminating at amino acids 40 or 42, respectively (Quality Control Biochemicals, Hopkinton, earlier studies of younger littermates that coexpress APP swe and Hu PS1-A246E, in which we demonstrated MA). As previously reported, A␤ deposits in human brain were preferentially immunoreactive with the Ab42 antithat only mutant PS1 influences APP processing in a manner that leads to increased concentrations of serum ( Figure 5A ; Iwatsubo et al., 1994 Iwatsubo et al., , 1995 Iwatsubo et al., , 1996 Gravina et al., 1995; Lemere et al., 1996) , and this immu-A␤1-42 in brain (Borchelt et al., 1996b) . However, it is not entirely clear whether the accelerated rate of A␤ noreactivity was blocked by synthetic A␤1-42 peptides ( Figure 5B ). In AD brain, Ab40 appeared to recognize deposition that occurs in the APP swe ϫ Hu PS1-A246E mice is due solely to increases in the levels of A␤1-42. only a subset of the very densely packed A␤ deposits ( Figures 5C and 5D ). In contrast, the majority of amyloid Based on in vitro aggregation studies (Jarrett et al., 1993) , which show A␤1-42 to be more fibrillogenic, and deposits in both the cortex and hippocampus of the Hu PS1-A246E ϫ APP swe transgenic mice showed Ab40 immunocytochemical studies of brains from sporadic AD (Iwatsubo et al., 1994; Gravina et al., 1995) , Swedish immunoreactivity (compare Figures 5E and 5G) . The immunoreactivity of both antibodies in the brains of these kindreds of familial AD (Mann et al., 1996) , and Down's Syndrome (Iwatsubo et al., 1995; Lemere et al., 1996) , transgenic mice was completely blocked by the relevant peptide antigen (Figures 5F and 5H ). Interestingly, in the which show that A␤1-42 is deposited early and selectively, we predicted that the A␤ deposits occurring in sections from mouse brain, the numbers of Ab40 and Ab42 immunoreactive deposits were lower than preour double transgenic mice would be immunoreactive with antibodies to A␤1-42 (Borchelt et al., 1996b) . Howdicted from 6E10 immunostaining or silver staining. Moreover, both the Ab42 and Ab40 antibodies seemed ever, we discovered that the majority of A␤ deposits in our double transgenic mice were not immunoreactive to be most reactive with the dense core structures in the center of the deposit. To confirm the Ab42 and Ab40 with either of two polyclonal antisera to the C-terminus not recognized by antibodies to A␤1-42. Second, it is possible that the Ab42 antibody discriminately recognizes a specific conformation of A␤1-42 fibrils. However, all tissues are denatured in 70% formic acid prior to immunostaining. Third, A␤1-42 fibrils may, in mice, form structures that are highly resistant to denaturants, thus precluding detection. Finally, exoproteolytic activities in mouse brain may degrade the deposited A␤1-42 peptides to reveal the Ab40 epitope (which is removed more slowly). Consistent with the latter two scenarios, Ab40 and Ab42 antisera recognized only ‫%07ف‬ and 20%, respectively, of the available A␤ deposits. Moreover, both antibodies appeared to preferentially reveal only the most densely packed core of the deposit. Thus, it is not presently clear whether the relative frequency and intensity of immunostaining with the Ab40 and Ab42 antibodies accurately reflects antigen abundance or antigen availability.
Although it is not clear whether increased A␤1-42 is the only driving force behind the accelerated A␤ deposition that occurred in our double transgenic mice, our new findings add to the growing body of evidence supporting the view (Selkoe, 1997) that amyloid deposition is an early and critical event in the pathogenesis of AD. Previous studies have established that mutations in APP occur in kindreds of familial AD (McKhann et al., 1984; Chartier-Harlin et al., 1991; Goate et al., 1991; Naruse et al., 1991) and that these mutations all alter proteolytic processing to favor the formation of A␤1-42 peptides (Iwatsubo et al., 1994; Gravina et al., 1995) buffered saline with 10 g/ml of peptide antigen. Notably, in addition and Down's Syndrome (Iwatsubo et al., 1995;  Lemere to the plaque immunostaining detected by Ab42, many neuronal profiles appeared to be specifically stained (immunoreactivity was et al., 1996) indicate that A␤1-42 deposition is an early completely competed with relevant peptide antigen). The signifievent in disease pathogenesis. Adding to this large body cance of this immunostaining is not clear at present, as no other of evidence, we now demonstrate that mutant PS1 acts A␤ antibody produced a similar pattern of immunostaining.
synergistically with mutant APP to markedly accelerate A␤ deposition in the CNS of transgenic mice. Collectively, of A␤1-42 (Ab42 and 3542) but instead were stained these findings support the view that A␤ deposition is an with antisera to A␤1-40 (Ab40 and 3540). All immunoreearly and significant event in the pathogenesis of AD. activity with both sets of antibodies could be completely competed with the relevant peptide antigen. Impor-
Experimental Procedures
tantly, our analyses of human AD brain, using the polyclonal antibodies to A␤1-42 peptides, revealed large Transgenic Mice numbers of A␤ deposits, whereas the A␤1-40 antibodies Most of the transgenic animals used in the present study are older recognized relatively few deposits; these results are fully littermates of animals used in previous examinations of A␤ peptide consistent with earlier immunocytochemical studies levels (Borchelt et al., 1996b) . All four genotypes examined (APP swe ϫ Hu PS1-A246E; APP swe ϫ wild-type Hu PS1, APP swe only, with a variety of monoclonal antibodies (Iwatsubo et al., and Hu PS1-A246E only) were represented in offspring that were Gravina et al., 1995; Lemere et al., 1996) . generated from matings between APP swe transgenic mice (strain Thus, we believe that the antibodies used in our study may be deposited more readily in mice; deposition of A␤1-40 was observed in mice expressing high levels of Hu APP695 with the Swedish mutations (Hsiao et al.,
Immunoctyochemistry and Histology
1996). However, this scenario does not explain why the Twelve-month-old transgenic mice that coexpress wild-type or Hu PS1-A246E and APP swe, express APP swe alone, and express Hu majority of deposits in our double transgenic mice were PS1-A246E alone were perfused with 1ϫ Dulbecco's phosphateBorchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et buffered saline (pH 7.1; Gibco BRL, Life Technologies, Grand Island, al. (1996b) . Familial Alzheimer's disease-linked presenilin 1 variants NY) followed by 4% paraformaldehyde, buffered with 1ϫ Dulbecco's elevate A␤1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013. phosphate-buffered saline (pH 7.1). Immunostaining with mAb 10D5, 6E10, and 4G8 was performed on paraffin-embedded, 10 m secBoteva, K., Vitek, M., Mitsuda, H., de Silva, H., Xu, P.-T., Small, G., tions (supported on Vectabond-coated slides). Immunostaining with and Gilbert, J.R. (1996) . Mutation analysis of presenilin 1 gene in the rabbit polyclonal antibodies Ab40 and Ab42 was performed Alzheimer's disease. Lancet 347, 130-131. on free-floating frozen sections. Prior to immunostaining, paraffinCai, X.-D., Golde, T.E., and Younkin, S.G. (1993) . Release of excess embedded sections were deparaffinized by oven heating, followed amyloid ␤ protein from a mutant amyloid ␤ protein precursor. Sciby a 3 min incubation in 70% formic acid (longer incubations diminence 259, 514-516. ish tissue integrity) and further deparaffinization in xylene followed Campion, D., Brice, A., Dumanchin, C., Puel, M., Baulac, M., De la by washes in 100% ethanol, 95% ethanol, 70% ethanol, and water.
Sayette, V., Hannequin, D., Duyckaerts, C., Michon, A., Martin, C., Endogenous peroxidase activities were quenched by 30 min incubaet al. (1996) . A novel presenilin 1 mutation resulting in familial Alzheitions in 3% H2O2 (in methanol) before sections were microwaved mer's disease with an onset age of 29 years. Neuroreport 7, 1582-for 5-7 min in water, cooled for 5 min, rinsed with water, and then 1584. washed in Tris-buffered saline (TBS; 0.05 M Tris-Cl [pH 7.6] and Chapman, J., Asherov, A., Wang, N., Treves, T.A., Korczyn, A.D., 0.25 M NaCl). All free-floating sections stained for A␤ were treated and Goldfarb, L.G. (1995) . Familial Alzheimer's disease associated with 70% formic acid for 3 min prior to immunostaining. Nonspecific with S182 codon 286 mutation. Lancet 346, 1040. epitopes were then blocked with 3% normal goat serum and 0.1% Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Triton X-100 in TBS. After 1 hr of blocking, primary antibodies Ab40
Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., (Quality Control Biochemicals, Hopkinton, MA), Ab42 (Quality Conand Mullan, M. (1991) . Early-onset Alzheimer's disease caused by trol Biochemicals, Hopkinton, MA), 10D5 (a gift from Dr. Dale Shenk, mutations at codon 717 of the ␤-amyloid precursor protein gene. Athena Neurosciences, South San Francisco, CA), 6E10 (Kim et al., Nature 353, 844-846. 1990 ), or 4G8 (Kim et al., 1990) were diluted to a final concentration of 5 g/ml in TBS with 2% normal goat serum and incubated overCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., night at 4ЊC in a humid chamber. Sections were then washed in TBS Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D.J. (1992). 3 times for 5 min each and incubated with secondary antibodies and Mutation of the ␤-amyloid precursor protein in familial Alzheimer's peroxidase-coupled streptavidin as described by the manufacturer disease increases ␤-protein production. Nature 360, 672-674. (Vectastain ABC Kit; Vector Laboratories, Incorporated, Burlingame, Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, CA). All sections were lightly counter-stained with hematoxylin and G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) . eosin, following standard histological procedures.
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid ␤-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72.
